The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database. The Food and Drug Administration (FDA) has approved the ...

Families pay thousands of dollars to store their children’s stem cells with the hope of a healthier future. But the cells are rarely useful, and sometimes contaminated. Anna Lazos with her son and ...

January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

For a time, cord blood banker Cryo-Cell International and its partner Duke University seemed to be flying high together on the hope of using cord blood for pediatric neurological conditions. Yet in ...

NEW YORK (Reuters) - An experimental stem cell therapy developed by Asterias Biotherapeutics restored some movement to patients paralyzed by recent spinal cord injuries, according to interim data from ...

Though still at an early stage, experts said the use of cord blood could help address India’s chronic shortage of donor blood and provide safer transfusion options for vulnerable preterm infants.